Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.89
+0.05 (0.36%)
Apr 29, 2026, 11:25 AM EDT - Market open
Trevi Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$21.55
Upside
+55.15%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +36.79% | Apr 17, 2026 |
| Jones Trading | Jones Trading | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +72.79% | Mar 19, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +29.59% | Mar 18, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +36.79% | Mar 18, 2026 |
| Needham | Needham | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +72.79% | Mar 18, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +36.79% | Mar 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +51.19% | Mar 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +51.19% | Jan 9, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +36.79% | Jan 8, 2026 |
| Stifel | Stifel | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +29.59% | Dec 19, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $16 | Buy | Maintains | $13 → $16 | +15.19% | Nov 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +36.79% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +72.79% | Nov 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 → $19 | Buy | Maintains | $18 → $19 | +36.79% | Nov 14, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $11 → $21 | Strong Buy | Maintains | $11 → $21 | +51.19% | Nov 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $18 | Buy | Initiates | $18 | +29.59% | Aug 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.